benzeneacetamides

Preferred Label : benzeneacetamides;

MeSH definition : Compounds based on benzeneacetamide, that are similar in structure to ACETANILIDES.;

MeSH synonym : 2-phenylacetamides;

Is substance : O;

Details

Origin ID

D044482;

UMLS CUI

C1257914;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- 2-phenylacetamide [Substance BNPC]
Record concept(s)
- benzeneacetamides [MeSH concept]
Related MeSH Supplementary Concept(s)
- (2R)-N-(1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl)-2-((1R)-3,3-difluorocyclopentyl)-2-hydroxy-2-phenylacetamide [MeSH Supplementary Concept]
- 2,2-dimethyl-6 beta-phenylacetamidopenam-3 alpha-ol S-oxide [MeSH Supplementary Concept]
- 2-(1-(2-(2,3-dihydro-1-benzofuran-5-yl)ethyl)piperidin-3-yl)-2,2-diphenylacetamide [MeSH Supplementary Concept]
- 2-(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-N-isopropyl-2-phenylacetamide [MeSH Supplementary Concept]
- 2-(2-amino-5-bromo-N-methylpyridine-3-sulfonamido)-N-(4-methoxyphenyl)acetamide [MeSH Supplementary Concept]
- 2-(3,5-bis-trifluoromethylphenyl)-N-(4-(4-fluoro-2-methylphenyl)-6-(3-hydroxy-2-hydroxymethylpyrrolidin-1-yl)pyridin-3-yl)-N-methylisobutyramide [MeSH Supplementary Concept]
- 2-(3,5-difluorophenyl)-N-(6-((4-fluorophenyl)methylamino)-2-morpholino-3-pyridyl)acetamide [MeSH Supplementary Concept]
- 2-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide [MeSH Supplementary Concept]
- 2-(4-(6-cyclohexyloxy-2-naphthyloxy)phenylacetamide)benzoic acid [MeSH Supplementary Concept]
- 2-(4-chloro-2-(3-chloro-5-cyanobenzoyl)phenoxy)-N-(2-methyl-4 ((propionylamino)sulfonyl)phenyl)acetamide [MeSH Supplementary Concept]
- 2-(4-cyanophenyl)-N-(1-(1-(N,1-diphenylmethylsulfonamido)propan-2-yl)piperidin-4-yl)acetamide [MeSH Supplementary Concept]
- 2-(4-cyclopropylphenyl)-N-(1-(5-((2,2,2-trifluoroethyl)oxo)pyridin-2-yl)ethyl)acetamide [MeSH Supplementary Concept]
- 2-(dimethylamino)-2-(2-ethylphenyl)-N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)acetamide [MeSH Supplementary Concept]
- 2-hydroxy-2-phenyl-N,N-diethylacetamide [MeSH Supplementary Concept]
- 2-isothiocyanato-4,5-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)benzeneacetamide [MeSH Supplementary Concept]
- 2-isothiocyanato-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)benzeneacetamide [MeSH Supplementary Concept]
- 2-phenylacetamide [MeSH Supplementary Concept]
- 3,3-diphenyl-3-dimethylcarbamoyl-1-propyne [MeSH Supplementary Concept]
- 3,4-dichloro-N-methyl-N-(2-(1-delta(3)-pyrrolinyl)-cyclohexyl)benzeneacetamide [MeSH Supplementary Concept]
- 3,4-dichloro-N-methyl-N-(2-(pyrrolidin-1-yl)-1,2,3,4-tetrahydro-5-hydroxynaphthalen-1-yl)benzeneacetamide [MeSH Supplementary Concept]
- 3,4-dichloro-N-methyl-N-(3-methylene-2-oxo-8-(1-pyrrolidinyl)-1-oxaspiro(4,5)dec-7-yl)benzeneacetamide [MeSH Supplementary Concept]
- 3-(4-(4-fluorophenyloxy)phenyl)-2-oxopyrrolidine-4-hydroxamic acid [MeSH Supplementary Concept]
- 3-chloro-4-hydroxyphenylacetamide [MeSH Supplementary Concept]
- 3-phenylacetylamino-2,6-piperidinedione [MeSH Supplementary Concept]
- 4-(2-amino-1-methyl-2-oxoethyl)phenyl trifluoromethanesulfonate [MeSH Supplementary Concept]
- 4-(N-(7-(3-(1-carbamoyl-1,1-diphenylmethyl)pyrrolidin-1-yl)hept-1-yl)-N-(n-propyl)amino)-1-(2,6-dimethoxybenzyl)piperidine [MeSH Supplementary Concept]
- A 1899 [MeSH Supplementary Concept]
- AGI-5198 [MeSH Supplementary Concept]
- AHR 10037 [MeSH Supplementary Concept]
- BW A879C [MeSH Supplementary Concept]
- BW B218C [MeSH Supplementary Concept]
- CB-839 [MeSH Supplementary Concept]
- CGK 733 [MeSH Supplementary Concept]
- DuP 747 [MeSH Supplementary Concept]
- E 3800 [MeSH Supplementary Concept]
- EAI045 [MeSH Supplementary Concept]
- Gue1654 [MeSH Supplementary Concept]
- IEM 611 [MeSH Supplementary Concept]
- KF 4317 [MeSH Supplementary Concept]
- N,N'-((4-(diethylamino)phenyl)methylene)bis(2-phenylacetamide) [MeSH Supplementary Concept]
- N-(((4-chlorophenyl)carbamothioyl)amino)-2-phenylacetamide [MeSH Supplementary Concept]
- N-((1R)-2-(tertbutylamino)-2-oxo-1-(3-pyridyl)ethyl)-N-(4-tertbutylphenyl)furan-2-carboxamide [MeSH Supplementary Concept]
- N-((2-(cyclohexylthio)-6-(trifluoromethyl)pyridin-3-yl)methyl)-2-(3-fluoro-4-(methylsulfonamido)phenyl)propanamide [MeSH Supplementary Concept]
- N-((4'-hydroxybiphenyl-3-yl)methyl)-2-(3-(2-((-2-hydroxy-2-(4-hydroxy-3-((methylsulfonyl)amino)phenyl)ethyl)amino)-2-methylpropyl)phenyl)acetamide [MeSH Supplementary Concept]
- N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide [MeSH Supplementary Concept]
- N-(1-(3-(3-oxo-2,3-dihydrobenzo(1,4)oxazin-4-yl)propyl)piperidin-4-yl)-2-phenylacetamide [MeSH Supplementary Concept]
- N-(1-hydroxy-3-oxoheptadeca-4,6-dien-2-yl)-2-phenylacetamide [MeSH Supplementary Concept]
- N-(2,6-dimethylphenyl)-2-(N-(2-furylmethyl)(4-(1,2,3,4-tetraazolyl)phenyl)carbonylamino)-2-(4-hydroxy-3-methoxyphenyl)acetamide [MeSH Supplementary Concept]
- N-(2-(4-t-butylbenzyl)-3-(pivaloyloxy)propyl)-2-(3-chloro-4-(methylsulfonylamino)phenyl)propionamide [MeSH Supplementary Concept]
- N-(2-(4-t-butylbenzyl)-3-(pivaloyloxy)propyl)-2-(3-fluoro-4-(methylsulfonylamino)phenyl)propionamide [MeSH Supplementary Concept]
- N-(2-diethylaminoethyl)-2',6'-mandeloxylidide [MeSH Supplementary Concept]
- N-(2-hydroxy-4-methylphenyl)acetamide [MeSH Supplementary Concept]
- N-(3-phenoxycinnamyl)acetohydroxamic acid [MeSH Supplementary Concept]
- N-(4-(4-chlorobenzyloxy)pyridin-2-yl)-2-(2,6-difluorophenyl)acetamide [MeSH Supplementary Concept]
- N-(4-benzyloxybenzyl)acetohydroxamic acid [MeSH Supplementary Concept]
- N-(4-isothiocyanatobenzyl)-2-(3-(tributylstannyl)phenyl)acetamide [MeSH Supplementary Concept]
- N-(4-methylphenyl)acetohydroxamic acid [MeSH Supplementary Concept]
- N-(5-(((5-tert-butyl-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-(((bis(hydroxymethyl)methyl)amino)methyl)benzeneacetamide [MeSH Supplementary Concept]
- N-(5-(2-chlorobenzoyl)-4-(3-chlorophenyl)thiazol-2-yl)-2-(4-ethanesulfonylphenyl)acetamide [MeSH Supplementary Concept]
- N-(5-amino-2-hydroxyphenyl)-2-phenylacetamide [MeSH Supplementary Concept]
- N-hydroxy-4-((N-(2-hydroxyethyl)-2-phenylacetamido)methyl)benzamide [MeSH Supplementary Concept]
- N-methylphenylacetohydroxamic acid [MeSH Supplementary Concept]
- N-nitroso-N-benzylacetamide [MeSH Supplementary Concept]
- N-phenethyl-2-phenylacetamide [MeSH Supplementary Concept]
- N-phenylacetyl-4-nitroaniline [MeSH Supplementary Concept]
- N2-((3-chlorophenyl)acetyl)-N-(4-nitrophenyl)glycinamide [MeSH Supplementary Concept]
- O-(2-diethylaminoethyl)-2',6'-mandeloxylidide [MeSH Supplementary Concept]
- PD 85639 [MeSH Supplementary Concept]
- R 4911 [MeSH Supplementary Concept]
- TEI-1194 [MeSH Supplementary Concept]
- TEI-2012 [MeSH Supplementary Concept]
- TMP920 [MeSH Supplementary Concept]
- U 69593 [MeSH Supplementary Concept]
- acetyltropic acid 2-pyridylmethylamide [MeSH Supplementary Concept]
- acetyltropic acid 4-pyridylmethylamide [MeSH Supplementary Concept]
- alpha-acetamido-N-benzyl-alpha-(furan-2-yl)acetamide [MeSH Supplementary Concept]
- alpha-hydroxy-alpha-ethyl-phenylacetamide [MeSH Supplementary Concept]
- antineoplaston A10 [MeSH Supplementary Concept]
- benzimidazole derivative XY123 [MeSH Supplementary Concept]
- benzylpenicilloyl G [MeSH Supplementary Concept]
- benzylpenicilloyl G polylysine [MeSH Supplementary Concept]
- benzylpenicilloyl-bovine-gamma-globulin [MeSH Supplementary Concept]
- benzylpenicilloyl-heptapeptide [MeSH Supplementary Concept]
- benzylpenicilloyl-n-propylamine [MeSH Supplementary Concept]
- benzylpenicilloylformyllysine [MeSH Supplementary Concept]
- bis(benzylpenicilloyl)-1,6-diaminohexane [MeSH Supplementary Concept]
- bovine gamma globulin-penicilloyl [MeSH Supplementary Concept]
- caroxazone [MeSH Supplementary Concept]
- coelenteramide [MeSH Supplementary Concept]
- epanolol [MeSH Supplementary Concept]
- epicainide [MeSH Supplementary Concept]
- fenaminstrobin [MeSH Supplementary Concept]
- figopitant [MeSH Supplementary Concept]
- glesatinib [MeSH Supplementary Concept]
- gliflumide [MeSH Supplementary Concept]
- hydroxyphenacetyl aminoclonidine [MeSH Supplementary Concept]
- ibuproxam [MeSH Supplementary Concept]
- lorcainide [MeSH Supplementary Concept]
- mandelohydroxamic acid [MeSH Supplementary Concept]
- nepafenac [MeSH Supplementary Concept]
- netupitant [MeSH Supplementary Concept]
- niravoline [MeSH Supplementary Concept]
- orysastrobin [MeSH Supplementary Concept]
- oxalyl bis(N-phenyl)hydroxamic acid [MeSH Supplementary Concept]
- oxiramide [MeSH Supplementary Concept]
- paraphenacyl [MeSH Supplementary Concept]
- penicilloyl polylysine [MeSH Supplementary Concept]
- penicilloyl-dextran [MeSH Supplementary Concept]
- phenacemide [MeSH Supplementary Concept]
- piragliatin [MeSH Supplementary Concept]
- squamosamide [MeSH Supplementary Concept]
- sulfamidochrysoidine [MeSH Supplementary Concept]
- tetrakis(alpha,alpha,alpha,alpha-O-phenylacetamide benzene)porphryin [MeSH Supplementary Concept]
See also
- acetanilides [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients